ANNOVIS BIO (ANVS) Stock Income Statement
NYSE:ANVS - New York Stock Exchange, Inc. - US03615A1088 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 25.17M | 26.69M | 45.03M | 25.51M | 14.54M | |||
| Research and Development | 18.48M | 20.00M | 38.79M | 16.52M | 8.48M | |||
| Selling, General, and Administrative Expenses | 6.68M | 6.70M | 6.24M | 9.00M | 6.06M | |||
| Operating Income | -25.17M | -26.69M | -45.03M | -25.51M | -14.54M | |||
| Interest Income/Expense | 4.54M | 331.90K | 667.90K | 180.00K | 10.00K | |||
| Other Income/Expense | -8.43M | 1.77M | -11.84M | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 40.00K | |||
| Income Before Taxes | -29.06M | -24.59M | -56.20M | -25.33M | -14.49M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | 0.00 | |||
| Net Income | -29.06M | -24.59M | -56.20M | -25.33M | -14.49M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.14 | -2.02 | -6.23 | -3.10 | -1.90 | |||
| Non GAAP EPS | -2.04 | -1.82 | -6.13 | -3.10 | -1.90 | |||
| Statistics | ||||||||
All data in USD